Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

ASND holding history

Ascendis Pharma A/S in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ASND overviewAll 13F holders of ASNDFull Q2 2026 holdings

Shares (Q2 2026)
377
Value
$100.6K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ASND by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026377$100.6K<0.1%−5−1.3%ReducedHolders
Q1 2026382$87.4K<0.1%−1,214−76.1%ReducedHolders
Q4 20251,596$340.3K<0.1%−563−26.1%ReducedHolders
Q3 20252,159$429.2K<0.1%+1,849+596.5%AddedHolders
Q2 2025310$53.5K<0.1%−5−1.6%ReducedHolders
Q1 2025315$49.1K<0.1%−46−12.7%ReducedHolders
Q4 2024361$49.7K<0.1%+73+25.3%AddedHolders
Q3 2024288$43.0K<0.1%−22−7.1%ReducedHolders
Q2 2024310$42.3K<0.1%−6−1.9%ReducedHolders
Q1 2024316$47.8K<0.1%+32+11.3%AddedHolders
Q4 2023284$35.8K<0.1%+74+35.2%AddedHolders
Q3 2023210$19.7K<0.1%+48+29.6%AddedHolders
Q2 2023162$14.5K<0.1%−901−84.8%ReducedHolders
Q1 20231,063$114.0K<0.1%−145−12.0%ReducedHolders
Q4 20221,208$147.5K<0.1%−45−3.6%ReducedHolders
Q3 20221,253$130.0K<0.1%+283+29.2%AddedHolders
Q2 2022970$90.0K<0.1%+357+58.2%AddedHolders
Q1 2022613$72.0K<0.1%−142−18.8%ReducedHolders
Q4 2021755$101.0K<0.1%−164−17.8%ReducedHolders
Q3 2021919$146.0K<0.1%+166+22.0%AddedHolders
Q2 2021753$99.0K<0.1%−63−7.7%ReducedHolders
Q1 2021816$106.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.